Better Therapeutics (BTTX) Q2 2023 Earnings Report
BTTX Q2 2023 EPS Results
- Actual EPS
- -$0.24
- Consensus EPS
- -$0.31
- Beat/Miss
- Beat by +$0.07
- One Year Ago EPS
- -$0.42
BTTX Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/09/2023
- Time
- After Close
- Conference Call
- Wednesday, August 9, 2023
Q2 2023 Earnings Call Audio
BTTX Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
BTTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2024 | 2024 (Q3) | ―- | -0.15 | ― | |
| Aug 08, 2024 | 2024 (Q2) | ―- | ― | ― | |
| May 10, 2024 | 2024 (Q1) | ―- | ― | ― | |
| Mar 27, 2024 | 2023 (Q4) | -0.12- | -0.37 | ― | |
| Nov 09, 2023 | 2023 (Q3) | -0.20-0.15 | -0.48 | 68.75% (+0.33) | |
| Aug 09, 2023 | 2023 (Q2) | -0.31-0.24 | -0.42 | 42.86% (+0.18) | |
| May 11, 2023 | 2023 (Q1) | -0.36-0.39 | -0.41 | 4.88% (+0.02) | |
| Mar 30, 2023 | 2022 (Q4) | -0.50-0.37 | -0.71 | 47.89% (+0.34) | |
| Nov 14, 2022 | 2022 (Q3) | -0.45-0.48 | -2.4 | 80.04% (+1.93) | |
| Aug 11, 2022 | 2022 (Q2) | -0.45-0.42 | -1.73 | 75.72% (+1.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
